# C & F Financial Corp: financial statements, quarterly

CFFI · Nasdaq · CIK 913341 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/cffi.md) · [Financials](/companies/cffi/financials.md) · [Filings](/companies/cffi/filings.md) · [Insiders](/companies/cffi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/cffi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [30.7](/filings/0000913341-24-000048.md) | [31.7 d](/filings/0000913341-26-000010.md) | [30.7](/filings/0000913341-25-000034.md) | [31.2](/filings/0000913341-25-000052.md) | [33.5](/filings/0000913341-25-000058.md) | [32.1 d](/filings/0000913341-26-000010.md) | [32.6](/filings/0000913341-26-000028.md) | [36.4](/filings/0000913341-26-000043.md) | [36.0](/filings/0000913341-25-000058.md) | [35.9 d](/filings/0000913341-26-000010.md) | [36.3](/filings/0000913341-26-000028.md) | [40.9](/filings/0000913341-26-000043.md) |
| Interest expense | $m | [7.2](/filings/0000913341-23-000054.md) | [8.5 d](/filings/0000913341-24-000009.md) | [9.6](/filings/0000913341-24-000026.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [1.3](/filings/0000913341-24-000048.md) | [1.1 d](/filings/0000913341-26-000010.md) | [0.6](/filings/0000913341-25-000034.md) | [1.2](/filings/0000913341-25-000052.md) | [1.3](/filings/0000913341-25-000058.md) | [1.2 d](/filings/0000913341-26-000010.md) | [1.1](/filings/0000913341-26-000028.md) | [1.9](/filings/0000913341-26-000043.md) | [1.7](/filings/0000913341-25-000058.md) | [1.4 d](/filings/0000913341-26-000010.md) | [1.6](/filings/0000913341-26-000028.md) | [2.2](/filings/0000913341-26-000043.md) |
| Net income | $m | [5.8](/filings/0000913341-24-000048.md) | [5.1 d](/filings/0000913341-26-000010.md) | [3.4](/filings/0000913341-25-000034.md) | [5.0](/filings/0000913341-25-000052.md) | [5.4](/filings/0000913341-25-000058.md) | [6.0 d](/filings/0000913341-26-000010.md) | [5.4](/filings/0000913341-26-000028.md) | [7.7](/filings/0000913341-26-000043.md) | [7.1](/filings/0000913341-25-000058.md) | [6.7 d](/filings/0000913341-26-000010.md) | [6.7](/filings/0000913341-26-000028.md) | [8.6](/filings/0000913341-26-000043.md) |
| Diluted EPS | $ per share | [1.71](/filings/0000913341-24-000048.md) | not reported | [1.01](/filings/0000913341-25-000034.md) | [1.50](/filings/0000913341-25-000052.md) | [1.65](/filings/0000913341-25-000058.md) | not reported | [1.66](/filings/0000913341-26-000028.md) | [2.37](/filings/0000913341-26-000043.md) | [2.18](/filings/0000913341-25-000058.md) | not reported | [2.08](/filings/0000913341-26-000028.md) | [2.63](/filings/0000913341-26-000043.md) |
| Basic EPS | $ per share | [1.71](/filings/0000913341-24-000048.md) | not reported | [1.01](/filings/0000913341-25-000034.md) | [1.50](/filings/0000913341-25-000052.md) | [1.65](/filings/0000913341-25-000058.md) | not reported | [1.66](/filings/0000913341-26-000028.md) | [2.37](/filings/0000913341-26-000043.md) | [2.18](/filings/0000913341-25-000058.md) | not reported | [2.08](/filings/0000913341-26-000028.md) | [2.63](/filings/0000913341-26-000043.md) |

- Revenue: us-gaap:Revenues
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $m | [2,422](/filings/0000913341-23-000054.md) | [2,438](/filings/0000913341-25-000016.md) | [2,470](/filings/0000913341-24-000026.md) | [2,492](/filings/0000913341-24-000040.md) | [2,551](/filings/0000913341-24-000048.md) | [2,563](/filings/0000913341-26-000010.md) | [2,613](/filings/0000913341-25-000034.md) | [2,686](/filings/0000913341-25-000052.md) | [2,711](/filings/0000913341-25-000058.md) | [2,768](/filings/0000913341-26-000043.md) | [2,814](/filings/0000913341-26-000028.md) | [2,810](/filings/0000913341-26-000043.md) |
| Total liabilities | $m | [2,221](/filings/0000913341-23-000054.md) | [2,221](/filings/0000913341-25-000016.md) | [2,253](/filings/0000913341-24-000026.md) | [2,273](/filings/0000913341-24-000040.md) | [2,323](/filings/0000913341-24-000048.md) | [2,336](/filings/0000913341-26-000010.md) | [2,377](/filings/0000913341-25-000034.md) | [2,445](/filings/0000913341-25-000052.md) | [2,457](/filings/0000913341-25-000058.md) | [2,506](/filings/0000913341-26-000043.md) | [2,548](/filings/0000913341-26-000028.md) | [2,532](/filings/0000913341-26-000043.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | [95.7](/filings/0000913341-23-000054.md) | [58.2](/filings/0000913341-25-000016.md) | [27.8](/filings/0000913341-24-000026.md) | [25.0](/filings/0000913341-24-000040.md) | [48.6](/filings/0000913341-24-000048.md) | [29.0](/filings/0000913341-26-000010.md) | [35.9](/filings/0000913341-25-000034.md) | [42.6](/filings/0000913341-25-000052.md) | [20.0](/filings/0000913341-25-000058.md) | [20.0](/filings/0000913341-26-000028.md) | [20.0](/filings/0000913341-26-000028.md) | not reported |
| Shareholders' equity | $m | [200](/filings/0000913341-23-000054.md) | [217](/filings/0000913341-25-000016.md) | [216](/filings/0000913341-24-000026.md) | [218](/filings/0000913341-24-000040.md) | [227](/filings/0000913341-24-000048.md) | [226](/filings/0000913341-26-000010.md) | [235](/filings/0000913341-25-000034.md) | [240](/filings/0000913341-25-000052.md) | [253](/filings/0000913341-25-000058.md) | [262](/filings/0000913341-26-000043.md) | [265](/filings/0000913341-26-000028.md) | [278](/filings/0000913341-26-000043.md) |

- Cash and equivalents: not reported
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [22.6 d](/filings/0000913341-24-000048.md) | [17.0 d](/filings/0000913341-26-000010.md) | [0.9](/filings/0000913341-25-000034.md) | [1.7 d](/filings/0000913341-25-000052.md) | [0.4 d](/filings/0000913341-25-000058.md) | [33.8 d](/filings/0000913341-26-000010.md) | [3.2](/filings/0000913341-26-000028.md) | [(4.4) d](/filings/0000913341-26-000043.md) | [23.4 d](/filings/0000913341-25-000058.md) | [2.2 d](/filings/0000913341-26-000010.md) | [(7.6)](/filings/0000913341-26-000028.md) | [24.7 d](/filings/0000913341-26-000043.md) |
| Capital expenditure | $m | [0.4 d](/filings/0000913341-24-000048.md) | [0.4 d](/filings/0000913341-26-000010.md) | [0.5](/filings/0000913341-25-000034.md) | [0.5 d](/filings/0000913341-25-000052.md) | [2.0 d](/filings/0000913341-25-000058.md) | [0.4 d](/filings/0000913341-26-000010.md) | [0.3](/filings/0000913341-26-000028.md) | [0.6 d](/filings/0000913341-26-000043.md) | [0.7 d](/filings/0000913341-25-000058.md) | [0.8 d](/filings/0000913341-26-000010.md) | [0.3](/filings/0000913341-26-000028.md) | [2.4 d](/filings/0000913341-26-000043.md) |
| Dividends paid | $m | [1.5 d](/filings/0000913341-24-000048.md) | [1.5 d](/filings/0000913341-26-000010.md) | [1.5](/filings/0000913341-25-000034.md) | [1.5 d](/filings/0000913341-25-000052.md) | [1.4 d](/filings/0000913341-25-000058.md) | [1.4 d](/filings/0000913341-26-000010.md) | [1.5](/filings/0000913341-26-000028.md) | [1.5 d](/filings/0000913341-26-000043.md) | [1.5 d](/filings/0000913341-25-000058.md) | [1.5 d](/filings/0000913341-26-000010.md) | [1.6](/filings/0000913341-26-000028.md) | [1.6 d](/filings/0000913341-26-000043.md) |
| Share repurchases | $m | [1.4 d](/filings/0000913341-24-000048.md) | [1.4 d](/filings/0000913341-26-000010.md) | [1.0](/filings/0000913341-25-000034.md) | [3.5 d](/filings/0000913341-25-000052.md) | [3.2 d](/filings/0000913341-25-000058.md) | [1.0 d](/filings/0000913341-26-000010.md) | [0.4](/filings/0000913341-26-000028.md) | [0.0 d](/filings/0000913341-26-000043.md) | [0.0 d](/filings/0000913341-25-000058.md) | [0.5 d](/filings/0000913341-26-000010.md) | [0.6](/filings/0000913341-26-000028.md) | [0.4 d](/filings/0000913341-26-000043.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [3,511](/filings/0000913341-23-000054.md) | [3,465](/filings/0000913341-24-000026.md) | [3,425](/filings/0000913341-24-000040.md) | [3,392](/filings/0000913341-24-000048.md) | [3,371](/filings/0000913341-25-000034.md) | [3,343](/filings/0000913341-25-000052.md) | [3,258](/filings/0000913341-25-000058.md) | [3,235](/filings/0000913341-26-000028.md) | [3,239](/filings/0000913341-26-000043.md) | [3,238](/filings/0000913341-25-000058.md) | [3,248](/filings/0000913341-26-000028.md) | [3,252](/filings/0000913341-26-000043.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 3,251,691 at 2026-08-06, from the cover of the [10-Q filed 2026-08-10](/filings/0000913341-26-000043.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.